A Consensus on Criteria for Cure of Acromegaly
Identifieur interne : 002489 ( PascalFrancis/Corpus ); précédent : 002488; suivant : 002490A Consensus on Criteria for Cure of Acromegaly
Auteurs : A. Giustina ; P. Chanson ; M. D. Bronstein ; A. Klibanski ; S. Lamberts ; F. F. Casanueva ; P. Trainer ; E. Ghigo ; K. Ho ; S. MelmedSource :
- The Journal of clinical endocrinology and metabolism [ 0021-972X ] ; 2010.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Objective: The Acromegaly Consensus Group met in April 2009 to revisit the guidelines on criteria for cure as defined in 2000. Participants: Participants included 74 neurosurgeons and endocrinologists with extensive experience of treating acromegaly. Evidence/Consensus Process: Relevant assays, biochemical measures, clinical outcomes, and definition of disease control were discussed, based on the available published evidence, and the strength of consensus statements was rated. Conclusions: Criteria to define active acromegaly and disease control were agreed, and several significant changes were made to the 2000 guidelines. Appropriate methods of measuring and achieving disease control were summarized.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 10-0357203 INIST |
---|---|
ET : | A Consensus on Criteria for Cure of Acromegaly |
AU : | GIUSTINA (A.); CHANSON (P.); BRONSTEIN (M. D.); KLIBANSKI (A.); LAMBERTS (S.); CASANUEVA (F. F.); TRAINER (P.); GHIGO (E.); HO (K.); MELMED (S.) |
AF : | Department of Medical and Surgical Sciences University of Brescia/25018 Montichiari/Italie (1 aut.); Assistance Publique-Hôpitaux de Paris et Université Paris-Sud 11 Department of Endocrinology and Reproductive Diseases/94275 Le Kremlin-Bicêtre/France (2 aut.); Neuroendocrine Unit Division of Endocrinology and Metabolism, University of Sao Paulo Medical School/05311-970 Sao Paulo/Brésil (3 aut.); Neuroendocrine Unit Massachusetts General Hospital and Harvard Medical School/Boston, Massachusetts 02114/Etats-Unis (4 aut.); Department of Internal Medicine Division of Endocrinology, Erasmus Medical Center/3000 CA Rotterdam/Pays-Bas (5 aut.); Division of Endocrinology CHUS Department of Medicine, Santiago de Compostela University/15782 Santiago de Compostela/Espagne (6 aut.); Department of Endocrinology Christie Hospital/Manchester M20 4BX/Royaume-Uni (7 aut.); Division of Endocrinology University of Turin/10129 Turin/Italie (8 aut.); Pituitary Research Unit Garvan Institute of Medical Research/Sydney, New South Wales 2010/Australie (9 aut.); Department of Medicine Cedars-Sinai Medical Center/Los Angeles, California 90048/Etats-Unis (10 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | The Journal of clinical endocrinology and metabolism; ISSN 0021-972X; Coden JCEMAZ; Etats-Unis; Da. 2010; Vol. 95; No. 7; Pp. 3141-3148; Bibl. 98 ref. |
LA : | Anglais |
EA : | Objective: The Acromegaly Consensus Group met in April 2009 to revisit the guidelines on criteria for cure as defined in 2000. Participants: Participants included 74 neurosurgeons and endocrinologists with extensive experience of treating acromegaly. Evidence/Consensus Process: Relevant assays, biochemical measures, clinical outcomes, and definition of disease control were discussed, based on the available published evidence, and the strength of consensus statements was rated. Conclusions: Criteria to define active acromegaly and disease control were agreed, and several significant changes were made to the 2000 guidelines. Appropriate methods of measuring and achieving disease control were summarized. |
CC : | 002A16E; 002A28; 002B21A01 |
FD : | Acromégalie; Consensus; Critère; Guérison; Endocrinologie; Maladie métabolique; Nutrition; Obésité; Etat nutritionnel |
FG : | Endocrinopathie; Pathologie de l'hypophyse; Pathologie du système ostéoarticulaire; Trouble de la nutrition |
ED : | Acromegaly; Consensus; Criterion; Cure; Endocrinology; Metabolic diseases; Nutrition; Obesity; Nutritional status |
EG : | Endocrinopathy; Pituitary diseases; Diseases of the osteoarticular system; Nutrition disorder |
SD : | Acromegalia; Consenso; Criterio; Curación; Endocrinología; Metabolismo patología; Nutrición; Obesidad; Estado nutricional |
LO : | INIST-6022.354000194728110090 |
ID : | 10-0357203 |
Links to Exploration step
Pascal:10-0357203Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">A Consensus on Criteria for Cure of Acromegaly</title>
<author><name sortKey="Giustina, A" sort="Giustina, A" uniqKey="Giustina A" first="A." last="Giustina">A. Giustina</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Medical and Surgical Sciences University of Brescia</s1>
<s2>25018 Montichiari</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chanson, P" sort="Chanson, P" uniqKey="Chanson P" first="P." last="Chanson">P. Chanson</name>
<affiliation><inist:fA14 i1="02"><s1>Assistance Publique-Hôpitaux de Paris et Université Paris-Sud 11 Department of Endocrinology and Reproductive Diseases</s1>
<s2>94275 Le Kremlin-Bicêtre</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bronstein, M D" sort="Bronstein, M D" uniqKey="Bronstein M" first="M. D." last="Bronstein">M. D. Bronstein</name>
<affiliation><inist:fA14 i1="03"><s1>Neuroendocrine Unit Division of Endocrinology and Metabolism, University of Sao Paulo Medical School</s1>
<s2>05311-970 Sao Paulo</s2>
<s3>BRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Klibanski, A" sort="Klibanski, A" uniqKey="Klibanski A" first="A." last="Klibanski">A. Klibanski</name>
<affiliation><inist:fA14 i1="04"><s1>Neuroendocrine Unit Massachusetts General Hospital and Harvard Medical School</s1>
<s2>Boston, Massachusetts 02114</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lamberts, S" sort="Lamberts, S" uniqKey="Lamberts S" first="S." last="Lamberts">S. Lamberts</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Internal Medicine Division of Endocrinology, Erasmus Medical Center</s1>
<s2>3000 CA Rotterdam</s2>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Casanueva, F F" sort="Casanueva, F F" uniqKey="Casanueva F" first="F. F." last="Casanueva">F. F. Casanueva</name>
<affiliation><inist:fA14 i1="06"><s1>Division of Endocrinology CHUS Department of Medicine, Santiago de Compostela University</s1>
<s2>15782 Santiago de Compostela</s2>
<s3>ESP</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Trainer, P" sort="Trainer, P" uniqKey="Trainer P" first="P." last="Trainer">P. Trainer</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Endocrinology Christie Hospital</s1>
<s2>Manchester M20 4BX</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ghigo, E" sort="Ghigo, E" uniqKey="Ghigo E" first="E." last="Ghigo">E. Ghigo</name>
<affiliation><inist:fA14 i1="08"><s1>Division of Endocrinology University of Turin</s1>
<s2>10129 Turin</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ho, K" sort="Ho, K" uniqKey="Ho K" first="K." last="Ho">K. Ho</name>
<affiliation><inist:fA14 i1="09"><s1>Pituitary Research Unit Garvan Institute of Medical Research</s1>
<s2>Sydney, New South Wales 2010</s2>
<s3>AUS</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Melmed, S" sort="Melmed, S" uniqKey="Melmed S" first="S." last="Melmed">S. Melmed</name>
<affiliation><inist:fA14 i1="10"><s1>Department of Medicine Cedars-Sinai Medical Center</s1>
<s2>Los Angeles, California 90048</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0357203</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0357203 INIST</idno>
<idno type="RBID">Pascal:10-0357203</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002489</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">A Consensus on Criteria for Cure of Acromegaly</title>
<author><name sortKey="Giustina, A" sort="Giustina, A" uniqKey="Giustina A" first="A." last="Giustina">A. Giustina</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Medical and Surgical Sciences University of Brescia</s1>
<s2>25018 Montichiari</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chanson, P" sort="Chanson, P" uniqKey="Chanson P" first="P." last="Chanson">P. Chanson</name>
<affiliation><inist:fA14 i1="02"><s1>Assistance Publique-Hôpitaux de Paris et Université Paris-Sud 11 Department of Endocrinology and Reproductive Diseases</s1>
<s2>94275 Le Kremlin-Bicêtre</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bronstein, M D" sort="Bronstein, M D" uniqKey="Bronstein M" first="M. D." last="Bronstein">M. D. Bronstein</name>
<affiliation><inist:fA14 i1="03"><s1>Neuroendocrine Unit Division of Endocrinology and Metabolism, University of Sao Paulo Medical School</s1>
<s2>05311-970 Sao Paulo</s2>
<s3>BRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Klibanski, A" sort="Klibanski, A" uniqKey="Klibanski A" first="A." last="Klibanski">A. Klibanski</name>
<affiliation><inist:fA14 i1="04"><s1>Neuroendocrine Unit Massachusetts General Hospital and Harvard Medical School</s1>
<s2>Boston, Massachusetts 02114</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lamberts, S" sort="Lamberts, S" uniqKey="Lamberts S" first="S." last="Lamberts">S. Lamberts</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Internal Medicine Division of Endocrinology, Erasmus Medical Center</s1>
<s2>3000 CA Rotterdam</s2>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Casanueva, F F" sort="Casanueva, F F" uniqKey="Casanueva F" first="F. F." last="Casanueva">F. F. Casanueva</name>
<affiliation><inist:fA14 i1="06"><s1>Division of Endocrinology CHUS Department of Medicine, Santiago de Compostela University</s1>
<s2>15782 Santiago de Compostela</s2>
<s3>ESP</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Trainer, P" sort="Trainer, P" uniqKey="Trainer P" first="P." last="Trainer">P. Trainer</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Endocrinology Christie Hospital</s1>
<s2>Manchester M20 4BX</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ghigo, E" sort="Ghigo, E" uniqKey="Ghigo E" first="E." last="Ghigo">E. Ghigo</name>
<affiliation><inist:fA14 i1="08"><s1>Division of Endocrinology University of Turin</s1>
<s2>10129 Turin</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ho, K" sort="Ho, K" uniqKey="Ho K" first="K." last="Ho">K. Ho</name>
<affiliation><inist:fA14 i1="09"><s1>Pituitary Research Unit Garvan Institute of Medical Research</s1>
<s2>Sydney, New South Wales 2010</s2>
<s3>AUS</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Melmed, S" sort="Melmed, S" uniqKey="Melmed S" first="S." last="Melmed">S. Melmed</name>
<affiliation><inist:fA14 i1="10"><s1>Department of Medicine Cedars-Sinai Medical Center</s1>
<s2>Los Angeles, California 90048</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">The Journal of clinical endocrinology and metabolism</title>
<title level="j" type="abbreviated">J. clin. endocrinol. metab.</title>
<idno type="ISSN">0021-972X</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">The Journal of clinical endocrinology and metabolism</title>
<title level="j" type="abbreviated">J. clin. endocrinol. metab.</title>
<idno type="ISSN">0021-972X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acromegaly</term>
<term>Consensus</term>
<term>Criterion</term>
<term>Cure</term>
<term>Endocrinology</term>
<term>Metabolic diseases</term>
<term>Nutrition</term>
<term>Nutritional status</term>
<term>Obesity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Acromégalie</term>
<term>Consensus</term>
<term>Critère</term>
<term>Guérison</term>
<term>Endocrinologie</term>
<term>Maladie métabolique</term>
<term>Nutrition</term>
<term>Obésité</term>
<term>Etat nutritionnel</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Objective: The Acromegaly Consensus Group met in April 2009 to revisit the guidelines on criteria for cure as defined in 2000. Participants: Participants included 74 neurosurgeons and endocrinologists with extensive experience of treating acromegaly. Evidence/Consensus Process: Relevant assays, biochemical measures, clinical outcomes, and definition of disease control were discussed, based on the available published evidence, and the strength of consensus statements was rated. Conclusions: Criteria to define active acromegaly and disease control were agreed, and several significant changes were made to the 2000 guidelines. Appropriate methods of measuring and achieving disease control were summarized.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0021-972X</s0>
</fA01>
<fA02 i1="01"><s0>JCEMAZ</s0>
</fA02>
<fA03 i2="1"><s0>J. clin. endocrinol. metab.</s0>
</fA03>
<fA05><s2>95</s2>
</fA05>
<fA06><s2>7</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>A Consensus on Criteria for Cure of Acromegaly</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>GIUSTINA (A.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>CHANSON (P.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BRONSTEIN (M. D.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>KLIBANSKI (A.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>LAMBERTS (S.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>CASANUEVA (F. F.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>TRAINER (P.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>GHIGO (E.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>HO (K.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>MELMED (S.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Medical and Surgical Sciences University of Brescia</s1>
<s2>25018 Montichiari</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Assistance Publique-Hôpitaux de Paris et Université Paris-Sud 11 Department of Endocrinology and Reproductive Diseases</s1>
<s2>94275 Le Kremlin-Bicêtre</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Neuroendocrine Unit Division of Endocrinology and Metabolism, University of Sao Paulo Medical School</s1>
<s2>05311-970 Sao Paulo</s2>
<s3>BRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Neuroendocrine Unit Massachusetts General Hospital and Harvard Medical School</s1>
<s2>Boston, Massachusetts 02114</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Internal Medicine Division of Endocrinology, Erasmus Medical Center</s1>
<s2>3000 CA Rotterdam</s2>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Division of Endocrinology CHUS Department of Medicine, Santiago de Compostela University</s1>
<s2>15782 Santiago de Compostela</s2>
<s3>ESP</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Department of Endocrinology Christie Hospital</s1>
<s2>Manchester M20 4BX</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Division of Endocrinology University of Turin</s1>
<s2>10129 Turin</s2>
<s3>ITA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Pituitary Research Unit Garvan Institute of Medical Research</s1>
<s2>Sydney, New South Wales 2010</s2>
<s3>AUS</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Department of Medicine Cedars-Sinai Medical Center</s1>
<s2>Los Angeles, California 90048</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA20><s1>3141-3148</s1>
</fA20>
<fA21><s1>2010</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>6022</s2>
<s5>354000194728110090</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>98 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>10-0357203</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>The Journal of clinical endocrinology and metabolism</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Objective: The Acromegaly Consensus Group met in April 2009 to revisit the guidelines on criteria for cure as defined in 2000. Participants: Participants included 74 neurosurgeons and endocrinologists with extensive experience of treating acromegaly. Evidence/Consensus Process: Relevant assays, biochemical measures, clinical outcomes, and definition of disease control were discussed, based on the available published evidence, and the strength of consensus statements was rated. Conclusions: Criteria to define active acromegaly and disease control were agreed, and several significant changes were made to the 2000 guidelines. Appropriate methods of measuring and achieving disease control were summarized.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002A16E</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002A28</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B21A01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Acromégalie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Acromegaly</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Acromegalia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Consensus</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Consensus</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Consenso</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Critère</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Criterion</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Criterio</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Guérison</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Cure</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Curación</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Endocrinologie</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Endocrinology</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Endocrinología</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Maladie métabolique</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Metabolic diseases</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Metabolismo patología</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Nutrition</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Nutrition</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Nutrición</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Obésité</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Obesity</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Obesidad</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Etat nutritionnel</s0>
<s5>25</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Nutritional status</s0>
<s5>25</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Estado nutricional</s0>
<s5>25</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Endocrinopathie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Endocrinopathy</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Endocrinopatía</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Pathologie de l'hypophyse</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Pituitary diseases</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Hipófisis patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie du système ostéoarticulaire</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Diseases of the osteoarticular system</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema osteoarticular patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Trouble de la nutrition</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Nutrition disorder</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Trastorno nutricíon</s0>
<s5>40</s5>
</fC07>
<fN21><s1>228</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 10-0357203 INIST</NO>
<ET>A Consensus on Criteria for Cure of Acromegaly</ET>
<AU>GIUSTINA (A.); CHANSON (P.); BRONSTEIN (M. D.); KLIBANSKI (A.); LAMBERTS (S.); CASANUEVA (F. F.); TRAINER (P.); GHIGO (E.); HO (K.); MELMED (S.)</AU>
<AF>Department of Medical and Surgical Sciences University of Brescia/25018 Montichiari/Italie (1 aut.); Assistance Publique-Hôpitaux de Paris et Université Paris-Sud 11 Department of Endocrinology and Reproductive Diseases/94275 Le Kremlin-Bicêtre/France (2 aut.); Neuroendocrine Unit Division of Endocrinology and Metabolism, University of Sao Paulo Medical School/05311-970 Sao Paulo/Brésil (3 aut.); Neuroendocrine Unit Massachusetts General Hospital and Harvard Medical School/Boston, Massachusetts 02114/Etats-Unis (4 aut.); Department of Internal Medicine Division of Endocrinology, Erasmus Medical Center/3000 CA Rotterdam/Pays-Bas (5 aut.); Division of Endocrinology CHUS Department of Medicine, Santiago de Compostela University/15782 Santiago de Compostela/Espagne (6 aut.); Department of Endocrinology Christie Hospital/Manchester M20 4BX/Royaume-Uni (7 aut.); Division of Endocrinology University of Turin/10129 Turin/Italie (8 aut.); Pituitary Research Unit Garvan Institute of Medical Research/Sydney, New South Wales 2010/Australie (9 aut.); Department of Medicine Cedars-Sinai Medical Center/Los Angeles, California 90048/Etats-Unis (10 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>The Journal of clinical endocrinology and metabolism; ISSN 0021-972X; Coden JCEMAZ; Etats-Unis; Da. 2010; Vol. 95; No. 7; Pp. 3141-3148; Bibl. 98 ref.</SO>
<LA>Anglais</LA>
<EA>Objective: The Acromegaly Consensus Group met in April 2009 to revisit the guidelines on criteria for cure as defined in 2000. Participants: Participants included 74 neurosurgeons and endocrinologists with extensive experience of treating acromegaly. Evidence/Consensus Process: Relevant assays, biochemical measures, clinical outcomes, and definition of disease control were discussed, based on the available published evidence, and the strength of consensus statements was rated. Conclusions: Criteria to define active acromegaly and disease control were agreed, and several significant changes were made to the 2000 guidelines. Appropriate methods of measuring and achieving disease control were summarized.</EA>
<CC>002A16E; 002A28; 002B21A01</CC>
<FD>Acromégalie; Consensus; Critère; Guérison; Endocrinologie; Maladie métabolique; Nutrition; Obésité; Etat nutritionnel</FD>
<FG>Endocrinopathie; Pathologie de l'hypophyse; Pathologie du système ostéoarticulaire; Trouble de la nutrition</FG>
<ED>Acromegaly; Consensus; Criterion; Cure; Endocrinology; Metabolic diseases; Nutrition; Obesity; Nutritional status</ED>
<EG>Endocrinopathy; Pituitary diseases; Diseases of the osteoarticular system; Nutrition disorder</EG>
<SD>Acromegalia; Consenso; Criterio; Curación; Endocrinología; Metabolismo patología; Nutrición; Obesidad; Estado nutricional</SD>
<LO>INIST-6022.354000194728110090</LO>
<ID>10-0357203</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002489 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002489 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:10-0357203 |texte= A Consensus on Criteria for Cure of Acromegaly }}
This area was generated with Dilib version V0.6.33. |